E. Edmund Kim – författare

Combined positron emission tomography (PET) or single photon emission computed tomography (SPECT) with computed tomography (CT) has developed into the faste- growing imaging modality largely because combined PET or SPECT with CT data acquisition is highly synergistic in diagnosis and therapeutic evaluation. All currently available data indicate that integrated PET or SPECT/CT is more sensitive and s- ci?c than either of its constituent imaging methods alone and probably more so than images obtained from separate systems viewed side by side. The PET or SPECT/CT provides precise localization of the lesions, thereby increasing diagnostic speci?city particularly by reducing false-positive ?ndings. The other advantage of adding CT is that the transmission data obtained with the CT component is useful for attenuation correction of the emission data. This makes PET/CT 25%–30% faster than PET alone with standard attenuation–correction method, leading to higher patient throughput and a more comfortable examination, which typically lasts 30 minutes or less. With hybrid imaging, unique physiologic information bene?ts from a precise to- graphic localization. Simultaneous evaluation of metabolic and anatomic information about normal and disease processes is needed to answer complex clinical questions and also raise the level of con?dence of scan interpretation. It is always dif?cult to consider three dimensions in the mind’s eye and view the relationship of the viscera and fascial planes in transverse and vertical sections of the body’s structure. The introduction of modern imaging techniques has enormously expanded the already considerable importance of sectional anatomy.

Cancer cells dedifferentiate with repect to cell function; their vascularity is more leaky, but perfusion is heterogenerously reduced, and interstitial fluid pressure is high, severely retarding delivery of agents from the blood. Targeted imaging is designed to produce a detectable difference between tissue that is visualized with single photon and positron emission tomography, magnetic resonance imaging, computed tomography, or ultrasonography. This book uniquely reports strategies for the application of molecular targeted imaging agents such as antibodies, peptides, receptors and contrast agents in the biologic grading of tumors, differential diagnosis of tumors, prediction of therapeutic response and monitoring tumor response to treatment. This book also describes updated information about the imaging of tumor angiogenesis, hypoxia, apoptosis and gene delivery as well as expression in the understanding and utility of tumor molecular biology for better cancer management.

Clinical PET and PET/CT, 2nd Edition presents a valuable overview of the basic principles and clinical applications of PET and PET/CT. Practical information about updated PET and PET/CT scanners, imaging processing, correlation, and quantification of PET and PET/CT measurements is also presented.

Combined positron emission tomography (PET) or single photon emission computed tomography (SPECT) with computed tomography (CT) has developed into the faste- growing imaging modality largely because combined PET or SPECT with CT data acquisition is highly synergistic in diagnosis and therapeutic evaluation.

PET has been a valuable research tool in academic institutions since the '70s, but its move into clinical practice in community hospitals has just begun. PET has undergone spectacular growth in the fields of nuclear medicine, radiology, and oncology. The burgeoning world of PET is reflected in standing room only CME courses at scientific meetings such as the Radiology Society of North America and the Society for Nuclear Medicine. This book will provide nuclear medicine practitioners, radiologists, oncologists, and neurologists with a practical overview of the basic principles and clinical applications of PET. Emphasis is placed on the familiarization of normal distribution, artefacts, and common imaging agents such as FDG in conjunction with CT, MRI, and US to establish the clinical effectiveness of PET. Practical understanding of updated PET scanners, image process and quantification of PET measurements is also discussed. With contributions from leaders in the PET community, the book deals with the basic principles, instrumentation, fusion, radiopharmaceuticals, radiosynthesis, safety and cost analysis of PET. The clinical section of the book will focus on the technique and indications of PET. There is also a unique atlas as well as comprehensive coverage of essential clinical PET studies in neurology, cardiology, and oncology.

Cancer cells dedifferentiate with repect to cell function; their vascularity is more leaky, but perfusion is heterogenerously reduced, and interstitial fluid pressure is high, severely retarding delivery of agents from the blood. Targeted imaging is designed to produce a detectable difference between tissue that is visualized with single photon and positron emission tomography, magnetic resonance imaging, computed tomography, or ultrasonography. This book uniquely reports strategies for the application of molecular targeted imaging agents such as antibodies, peptides, receptors and contrast agents in the biologic grading of tumors, differential diagnosis of tumors, prediction of therapeutic response and monitoring tumor response to treatment. This book also describes updated information about the imaging of tumor angiogenesis, hypoxia, apoptosis and gene delivery as well as expression in the understanding and utility of tumor molecular biology for better cancer management.

Clinical PET and PET/CT, 2nd Edition presents a valuable overview of the basic principles and clinical applications of PET and PET/CT. Practical information about updated PET and PET/CT scanners, imaging processing, correlation, and quantification of PET and PET/CT measurements is also presented.

This atlas showcases cross-sectional anatomy for the proper interpretation of images generated from PET/MRI, PET/CT, and SPECT/CT applications. Hybrid imaging is at the forefront of nuclear and molecular imaging and enhances data acquisition for the purposes of diagnosis and treatment. Simultaneous evaluation of anatomic and metabolic information about normal and abnormal processes addresses complex clinical questions and raises the level of confidence of the scan interpretation. Extensively illustrated with high-resolution PET/MRI, PET/CT and SPECT/CT images, this atlas provides precise morphologic information for the whole body as well as for specific regions such as the head and neck, abdomen, and musculoskeletal system. Atlas and Anatomy of PET/MRI, PET/CT, AND SPECT/CT, Second Edition is a unique resource for physicians and residents in nuclear medicine, radiology, oncology, neurology, and cardiology.

This atlas showcases cross-sectional anatomy for the proper interpretation of images generated from PET/MRI, PET/CT, and SPECT/CT applications. Hybrid imaging is at the forefront of nuclear and molecular imaging and enhances data acquisition for the purposes of diagnosis and treatment. Simultaneous evaluation of anatomic and metabolic information about normal and abnormal processes addresses complex clinical questions and raises the level of confidence of the scan interpretation. Extensively illustrated with high-resolution PET/MRI, PET/CT and SPECT/CT images, this atlas provides precise morphologic information for the whole body as well as for specific regions such as the head and neck, abdomen, and musculoskeletal system. Atlas and Anatomy of PET/MRI, PET/CT, AND SPECT/CT, Second Edition is a unique resource for physicians and residents in nuclear medicine, radiology, oncology, neurology, and cardiology.

This atlas showcases cross-sectional anatomy for the proper interpretation of images generated from PET/MRI, PET/CT, and SPECT/CT applications.

Advanced routine imaging techniques have made it possible to diagnose localized abnormalities often before they have produced irreversible damage. PET permits visualization of the metabolic or physiologic characteristics of tumors. MRI shows exclusive morphologic abnormalities, and functional MRI depicts the motor and sensory status in the vicinity of tumors. MRS offers biochemical information of tumors and surrounding normal tissues. Combining PET, MRI and MRS information we should be able to differentiate tumors from non-tumor lesions, to characterize types or grades of tumors, and to monitor tumor regression, recurrence or response to therapy. This book reports updated techniques, instrumentation and clinical application of PET, MRI and MRS in cancer management.